Biotechnology in Italy - 麻豆原创 Summary, Competitive Analysis and Forecast to 2025
Summary
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Italian biotechnology market had total revenues of $17.5bn in 2020, representing a compound annual growth rate (CAGR) of 17.5% between 2016 and 2020.
- The medical/healthcare segment was the market's most lucrative in 2020, with total revenues of $7.3bn, equivalent to 41.7% of the market's overall value.
- The COVID-19 pandemic has brought about unprecedented levels of uncertainty in many sectors, making the future of biotechnology uncertain. However, in the mid- to long-term the market as a whole should benefit from rising investment in medicines and government support for scientific and technological innovation as part of the Next Generation Italia post-pandemic recovery plan.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Italy
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy
- Leading company profiles reveal details of key biotechnology market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Italy biotechnology market by value in 2020?
- What will be the size of the Italy biotechnology market in 2025?
- What factors are affecting the strength of competition in the Italy biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Italy's biotechnology market?
Table of Contents
1 Executive Summary
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. 麻豆原创 rivalry
1.6. Competitive Landscape
2 麻豆原创 Overview
2.1. 麻豆原创 definition
2.2. 麻豆原创 analysis
3 麻豆原创 Data
3.1. 麻豆原创 value
4 麻豆原创 Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 麻豆原创 Outlook
5.1. 麻豆原创 value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Do leading players have any notable weaknesses?
7.4. What has been the most significant M&A activity this year?
7.5. How might the COVID-19 pandemic affect the competitive landscape?
8 Company Profiles
8.1. A Menarini Industrie Farmaceutiche Riunite Srl
8.2. Recordati S.p.A.
8.3. Zambon Co SpA
8.4. AGC Biologics SpA
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related 麻豆原创Line research
10.4. About 麻豆原创Line
List of Tables
List of Tables
Table 1: Italy biotechnology industry value: $ billion, 2016-20
Table 2: Italy biotechnology industry category segmentation: $ billion, 2020
Table 3: Italy biotechnology industry geography segmentation: $ billion, 2020
Table 4: Italy biotechnology industry value forecast: $ billion, 2020-25
Table 5: A Menarini Industrie Farmaceutiche Riunite Srl: key facts
Table 6: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees
Table 7: Recordati S.p.A.: key facts
Table 8: Recordati S.p.A.: Annual Financial Ratios
Table 9: Recordati S.p.A.: Key Employees
Table 10: Zambon Co SpA: key facts
Table 11: Zambon Co SpA: Key Employees
Table 12: AGC Biologics SpA: key facts
Table 13: AGC Biologics SpA: Key Employees
Table 14: Italy size of population (million), 2016-20
Table 15: Italy gdp (constant 2005 prices, $ billion), 2016-20
Table 16: Italy gdp (current prices, $ billion), 2016-20
Table 17: Italy inflation, 2016-20
Table 18: Italy consumer price index (absolute), 2016-20
Table 19: Italy exchange rate, 2016-20
List of Figures
List of Figures
Figure 1: Italy biotechnology industry value: $ billion, 2016-20
Figure 2: Italy biotechnology industry category segmentation: % share, by value, 2020
Figure 3: Italy biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: Italy biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the biotechnology industry in Italy, 2020
Figure 6: Drivers of buyer power in the biotechnology industry in Italy, 2020
Figure 7: Drivers of supplier power in the biotechnology industry in Italy, 2020
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Italy, 2020
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Italy, 2020
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Italy, 2020
A Menarini Industrie Farmaceutiche Riunite Srl
Recordati S.p.A.
Zambon Co SpA
AGC Biologics SpA
听
听
*If Applicable.
